Serina Therapeutics Inc (SER)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Serina Therapeutics Inc Stock (SER) Company Profile

Serina Therapeutics Inc

Healthcare (1087)

Biotechnology (606)

(256) 327-9630

601 GENOME WAY, HUNTSVILLE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SER's Discussions on Twitter

Compare SER vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SER Serina Therapeutics Inc	2.57	63.50M	130.00K	-21.29M	-18.29M	-1.977
VRTX Vertex Pharmaceuticals Inc	522.74	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	804.43	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,005.05	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.68	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.07	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-14	Eingeleitet	H.C. Wainwright	Buy

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc Stock (SER) Company Profile

Compare SER vs VRTX, REGN, ARGX, MRNA, RVMD

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Some Parkinson’s patients showed sustained motor improvement in Serina’s study - Stock Titan

Serina Therapeutics (SER) Dips 2.40% to $2.44, Testing Key Support at $2.32Block Trade Flow - vinanet.vn

Serina Therapeutics, Inc. SEC Filing (Sep 1, 2026) - Stock Titan

Serina Therapeutics Establishes Flexible Equity Financing Agreement - The Globe and Mail

Serina Therapeutics Secures $25 Million Equity Financing Facility with Roth Principal - Minichart

Serina Therapeutics Sets Up $25 Million Equity Purchase Facility With Roth Principal Investments - TradingView

IPO Databook: Serina Therapeutics (SER US)Aug 2026 - Smartkarma

Serina TherapeuticsOffers Up To 12,500,000 Shares Of Common Stock By Roth Principal InvestmentsSEC Filing - TradingView

BTIG Maintains Serina Therapeutics(SER.US) With Buy Rating, Maintains Target Price $8 - Moomoo

Serina Therapeutics, Inc. announced that it expects to receive $25 million in funding from Roth Principal Investments, LLC - marketscreener.com

Serina (SER) Move: Ends Lower by 1.53% at $2.58 in the Latest Reading; Next Session: the Near-Term Reference Band Stretches From $2.45 to $2.71 in the Available RecordSwing Entry Signals - vinanet.vn

Serina Therapeutics Q2 loss widens to $(0.55) as revenue drops to zero - scanx.trade

Serina Therapeutics Completes Dosing for 8 Parkinson’s Patients - Stock Titan

Serina Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Serina Therapeutics Inc (SER) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

SER Q1 2026 Earnings: Wider Loss Falls Short of Estimates Despite Modest Share GainEarnings Trend Analysis - vinanet.vn

Serina Therapeutics Inc (SER) Stock News Today - TradingKey

Serina Therapeutics (SER) Holds Steady Above $2.24 Support, Up 0.43% in Measured SessionDelta Hedging - vinanet.vn

Serina Therapeutics (SER) Advances 5.83% to $2.18, Approaching Key Resistance at $2.29McClellan Summation - dars.gov.et

SER Q1 2026 Earnings: Wider-than-Expected Loss of -$0.58 per Share Signals Rising Pipeline CostsEarnings Call Highlights - vinanet.vn

Serina Therapeutics Inc. (SER) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues to Invest in PipelineReturn On Equity - dars.gov.et

Serina Therapeutics Inc (SER) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Serina Therapeutics Inc (SER) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Serina Therapeutics Inc (SER) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

SER|Serina Therapeutics Inc|Price:2.030|Chg%:-0.040 - TradingKey

Serina Therapeutics Market Sentiment - Benzinga España

Serina Therapeutics Inc (SER) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Serina Therapeutics Inc (SER) Balance Sheet - TradingKey

Serina Therapeutics, Inc. Revenue Breakdown – AMEX:SER - TradingView

Serina Therapeutics, Inc. Revenue Breakdown – TRADEGATE:2BO - TradingView

TradingKey - TradingKey

Serina Therapeutics Inc (SER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

SER|Serina Therapeutics Inc|Price:1.990|Chg%:-0.080 - TradingKey

Serina Therapeutics to present at BTIG Virtual Biotechnology Conference July 28-29, 2026 - Pluang

Serina Therapeutics, Inc. Amended CEO Employment Agreement and SEC Filing Details – July 2026 - Minichart

Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times

Serina Sets July 29 Virtual Investor Meetings at BTIG Event - Stock Titan

Serina Therapeutics (SER) Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Revenue PhaseEarnings Per Share - vinanet.vn

Form 4 Serina Therapeutics Inc For: 23 July By Investing.com - Investing.com Canada

Serina Therapeutics director Simon Farrell files initial beneficial ownership statement - Bitget

Director Simon Farrell awarded 30,500 options at Serina (SER) - Stock Titan

Serina Therapeutics, Inc. (SER) director Simon Farrell files Form 3 - Stock Titan

Serina Therapeutics Amends CEO Employment and Compensation Terms - TipRanks

Serina names Steve Ledger in amended CEO employment agreement - TradingView

Serina’s Parkinson’s trial doses all 8 first-cohort patients - Stock Titan

Serina Therapeutics Appoints Farrell Simon To Its Board Of Directors - TradingView

Serina Therapeutics Adds Industry Veteran to Board - TipRanks

Serina Therapeutics appoints Farrell Simon to Board, joins Audit and Compensation Committees - TradingView

Serina Therapeutics Appoints Farrell Simon to its Board of Directors - GlobeNewswire

Form 13D/A SERINA THERAPEUTICS For: 22 July By Investing.com - Investing.com Nigeria

Juvenescence group reports 27.3% Serina Therapeutics (SER) beneficial stake - Stock Titan

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SER